Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Fertility and Sterility

Volumn 100, Issue 3, 2013, Pages 742-747.e1

  Fatemi, Human M ^a   Polyzos, Nikolaos P ^a   Van Vaerenbergh, Inge ^a   Bourgain, Claire ^a   Blockeel, Christophe ^a   Alsbjerg, Birgit ^b   Papanikolaou, Evangelos G ^a   Humaidan, Peter ^b,c  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b SKIVE REGIONAL HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

GnRH agonist trigger; GnRH antagonist; hCG; luteal phase; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ARTICLE; BLOOD SAMPLING; ECHOGRAPHY; ESTROGEN BLOOD LEVEL; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE MATURATION; OVULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 84883457289     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.05.028     Document Type: Article

References (34)

1. S.S. Yen, O. Llerena, B. Little, and O.H. Pearson Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man J Clin Endocrinol Metab 28 1968 1763 1767
2. M.D. Damewood, W. Shen, H.A. Zacur, W.D. Schlaff, J.A. Rock, and E.E. Wallach Disappearance of exogenously administered human chorionic gonadotropin Fertil Steril 52 1989 398 400
3. J.D. Hoff, M.E. Quigley, and S.S. Yen Hormonal dynamics at midcycle: a reevaluation J Clin Endocrinol Metab 57 1983 792 796
4. J. Evans, and L.A. Salamonsen Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity Hum Reprod 28 2013 1610 1619
5. Y. Gonen, H. Balakier, W. Powell, and R.F. Casper Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization J Clin Endocrinol Metab 71 1990 918 922
6. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil Steril 56 1991 213 220
7. A.C. Yding, L.G. Westergaard, Y. Figenschau, K. Bertheussen, and F. Forsdahl Endocrine composition of follicular fluid comparing human chorionic gonadotrophin to a gonadotrophin-releasing hormone agonist for ovulation induction Hum Reprod 8 1993 840 843
8. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, and L. Westergaard GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
9. P. Humaidan, L. Bungum, M. Bungum, and A.C. Yding Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study Reprod Biomed Online 13 2006 173 178
10. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod Biomed Online 18 2009 630 634
11. P. Humaidan, B.H. Ejdrup, L.G. Westergaard, and A.C. Yding 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
12. P. Humaidan, S. Kol, and E.G. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524
13. E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil Steril 95 2011 1174 1177
14. P. Humaidan, E.G. Papanikolaou, D. Kyrou, B. Alsbjerg, N.P. Polyzos, and P. Devroey The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives Reprod Biomed Online 24 2012 134 141
15. P. Humaidan, I. Van Vaerenbergh, C. Bourgain, B. Alsbjerg, C. Blockeel, and F. Schuit Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles Hum Reprod 27 2012 3259 3272
16. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
17. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, and K. Diedrich Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J Clin Endocrinol Metab 88 2003 4186 4192
18. H.M. Fatemi The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online 19 Suppl 4 2009 4331
19. B.C. Fauser, and P. Devroey Reproductive biology and IVF: ovarian stimulation and luteal phase consequences Trends Endocrinol Metab 14 2003 236 242
20. A. Tavaniotou, and P. Devroey Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles Fertil Steril 80 2003 654 655
21. A. Tavaniotou, C. Albano, J. Smitz, and P. Devroey Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix Hum Reprod 16 2001 663 667
22. R.F. Casper, and S.S. Yen Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor Science 205 1979 408 410
23. N. Sugino, S. Kashida, S. Takiguchi, A. Karube, and H. Kato Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy J Clin Endocrinol Metab 85 2000 3919 3924
24. X.F. Wang, F.Q. Xing, and S.L. Chen Interleukin-1beta expression on ovarian granulosa cells and its clinical implication in women undergoing in vitro fertilization Di Yi Jun Yi Da Xue Xue Bao 22 2002 934 936
25. P. Licht, V. Russu, S. Lehmeyer, and L. Wildt Molecular aspects of direct LH/hCG effects on human endometrium - lessons from intrauterine microdialysis in the human female in vivo Reprod Biol 1 2001 10 19
26. M.L. Bonduelle, R. Dodd, I. Liebaers, S.A. Van, R. Williamson, and R. Akhurst Chorionic gonadotrophin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes Hum Reprod 3 1988 909 914
27. H.M. Fatemi, B. Popovic-Todorovic, P. Donoso, E. Papanikolaou, J. Smitz, and P. Devroey Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donors Reprod Biomed Online 17 2008 307 311
28. M. Filicori, J.P. Butler, and W.F. Crowley Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion J Clin Invest 73 1984 1638 1647
29. H.M. Fatemi, B. Popovic-Todorovic, E. Papanikolaou, P. Donoso, and P. Devroey An update of luteal phase support in stimulated IVF cycles Hum Reprod Update 13 2007 581 590
30. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, and J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715
31. J.C. Emperaire, I. Parneix, and A. Ruffie Luteal phase defects following agonist-triggered ovulation: a patient-dependent response Reprod Biomed Online 9 2004 22 27
32. M.B. Zelinski-Wooten, J.S. Hutchison, Y.A. Chandrasekher, D.P. Wolf, and R.L. Stouffer Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles J Clin Endocrinol Metab 75 1992 502 507
33. B.J. Cohlen, E.R. te Velde, G. Scheffer, R.J. van Kooij, C.P. Maria de Brouwer, and P. van Zonneveld The pattern of the luteinizing hormone surge in spontaneous cycles is related to the probability of conception Fertil Steril 60 1993 413 417
34. R.A. Miles, R.J. Paulson, R.A. Lobo, M.F. Press, L. Dahmoush, and M.V. Sauer Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study Fertil Steril 62 1994 485 490